Results 261 to 270 of about 715,867 (372)
Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden
ABSTRACT Background and Aims There is limited real‐world data on the prognosis of patients with cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (MASLD). We sought to describe the characteristics and assess the clinical course of MASLD‐cirrhosis.
Ying Shang +8 more
wiley +1 more source
A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosis [PDF]
Elliot B. Tapper +6 more
openalex +1 more source
Should Elective TIPS be Placed in Non‐Abstinent Patients With Alcohol‐Related Cirrhosis?
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Marika Rudler, Dominique Thabut
wiley +1 more source
ABSTRACT Background & Aims Metabolic associated steatotic liver disease (MASLD) is increasing in prevalence worldwide. Clinical practice is focused on identifying those with cirrhosis and monitoring for complications such as varices and hepatocellular carcinoma (HCC).
Rachael Barrett +5 more
wiley +1 more source
A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy. [PDF]
Fang J, Fang J.
europepmc +1 more source
ABSTRACT Background &Aims Growth differentiation factor‐15 (GDF‐15), a cell stress‐induced cytokine, is implicated in liver disease pathophysiology. We investigated GDF‐15 in cirrhosis, focusing on its association with disease‐driving pathomechanisms, platelet function, hepatic decompensation, and mortality.
Benedikt Silvester Hofer +22 more
wiley +1 more source
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy. [PDF]
Labenz C +16 more
europepmc +1 more source
Liver Transplantation for Primary Biliary Cirrhosis [PDF]
Carcassonne, Christian +4 more
core +1 more source

